Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

1.5K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.5K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

499
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
499
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

6.4K
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
6.4K
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

4.1K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
4.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multidisciplinary ambulatory management of malignant bowel obstruction (MAMBO) program in patients with advanced gynecological cancers: A prospective study.

Gynecologic oncology·2025
Same author

Cardiac myosin binding protein C correlate with cardiac troponin I during an exercise training program in patients with HFrEF.

ESC heart failure·2025
Same author

Reproductomics: Exploring the Applications and Advancements of Computational Tools.

Physiological research·2024
Same author

Reporting clinical error: Empowering the next generation through student-led interventions.

Medical teacher·2017
Same author

A role for mitogen kinase kinase 3 in pulmonary inflammation validated from a proteomic approach.

Pulmonary pharmacology & therapeutics·2014
Same author

The 1918-19 influenza pandemic revisited.

The journal of the Royal College of Physicians of Edinburgh·2013

Related Experiment Video

Updated: Apr 17, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

9.8K

Ischaemic postconditioning: cardiac protection after the event.

N Jivraj1, F Liew, M Marber

  • 1School of Medicine and BHF Centre of Excellence, Cardiovascular Division, King's College London, London, UK.

Anaesthesia
|February 17, 2015
PubMed
Summary

Cardiac ischaemic postconditioning offers cardioprotection by reducing reperfusion injury after heart attacks. However, its clinical benefits require large trials to overcome patient and application variability.

More Related Videos

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents
07:52

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents

Published on: June 2, 2015

12.9K
Pre-clinical Model of Cardiac Donation after Circulatory Death
06:26

Pre-clinical Model of Cardiac Donation after Circulatory Death

Published on: August 2, 2019

8.5K

Related Experiment Videos

Last Updated: Apr 17, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

9.8K
Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents
07:52

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents

Published on: June 2, 2015

12.9K
Pre-clinical Model of Cardiac Donation after Circulatory Death
06:26

Pre-clinical Model of Cardiac Donation after Circulatory Death

Published on: August 2, 2019

8.5K

Area of Science:

  • Cardiology
  • Cardiovascular Medicine
  • Ischaemic Heart Disease Research

Background:

  • Ischaemic heart disease is a leading global cause of death, necessitating novel cardioprotective strategies.
  • Cardiac ischaemic postconditioning is a promising technique to mitigate reperfusion injury.
  • Existing evidence shows infarct size reduction and improved ejection fraction with postconditioning.

Purpose of the Study:

  • To review the development of cardiac ischaemic postconditioning algorithms.
  • To highlight findings from current proof-of-concept trials.
  • To identify barriers to the clinical adoption of postconditioning.

Main Methods:

  • Review of current postconditioning algorithms and proof-of-concept trial data.
  • Analysis of factors influencing postconditioning efficacy.
  • Discussion of challenges for broad clinical implementation.

Main Results:

  • Postconditioning demonstrates potential for reducing reperfusion injury and improving cardiac function.
  • Efficacy is highly dependent on patient selection, timing, and endpoints.
  • Confounders like age, sex, medication, and comorbidities impact outcomes.

Conclusions:

  • Postconditioning's benefits can be attenuated, requiring careful patient selection and timely application.
  • Large-scale trials are essential to validate its efficacy and ensure robust clinical applicability.
  • Overcoming barriers is crucial for widespread adoption in clinical practice.